Back to search results

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Gabrail Cancer Center, Canton, Ohio, United States

    Contact: Study coordinator (Carrie Smith, RN) · csmith@gabrailcancercenter.com · 330-492-3345
    Contact: Principal Investigator (Nashat Gabrail, MD)

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States

    Contact: Study coordinator (Cancer Answer Line) · canceranswer@ccf.org · 866-223-8100
    Contact: Principal Investigator (James Wooley)
Study leads

  • Gabi Hanna, MD

    Study Director

    Lamassu Bio

View source on ClinicalTrials.gov(opens in a new tab)